Bellevue, Washington - CurvaFix, Inc., a cutting-edge medical equipment manufacturing company, has successfully raised $39 million in a Series C funding round led by Sectoral Asset Management and MVM Partners. This latest investment marks a significant milestone in the company's mission to advance fracture repair in curved bones, with a particular focus on Fragility Fractures of the Pelvis (FFP) and high-impact pelvic fractures.

CurvaFix has gained recognition in the medical industry for its groundbreaking work in developing implantable products that improve fracture repair in curved bones. The CurvaFix® IM Implant, the company's flagship innovation, is the world's first intramedullary device designed to follow the natural bone shape and effectively fill the space within curved bones, such as the pelvis.

"We are thrilled to have secured this substantial funding to further our mission of revolutionizing fracture repair in curved bones," said Steve Dimmer, founder and CEO of CurvaFix. "With the generous support of our investors, Sectoral Asset Management and MVM Partners, we are now better positioned to expand our product development and clinical trials, ultimately bringing the CurvaFix® IM Implant to the forefront of medical advancements."